Full Press Release Details
Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ: Friday, April 23, 2021: Hutchison China MediTech Limited ("HUTCHMED") (Nasdaq/AIM: HCM) announces that the non-performance based awards granted under the Long Term Incentive Plan ("LTIP") on April 20, 2020 to the following persons discharging managerial responsibilities were vested on April 20, 2021:-
| Award Holder | Number of American depositary shares ("ADS") | |
| Mr Simon To (Executive Director) | 2,397 1 | |
| Dr Dan Eldar (Non-executive Director ("NED")) | 2,397 | |
| Ms Edith Shih (NED) | 2,397 2 | |
| Mr Paul Carter (Independent Non-executive Director ("INED")) | 2,037 | |
| Dr Karen Ferrante (INED) | 2,397 | |
| Mr Graeme Jack (INED) | 2,397 | |
| Professor Tony Mok (INED) | 2,397 |
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Dr Dan Eldar | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Non-Executive Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Hutchison China MediTech Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | ADS each representing five Ordinary Shares of US$0.10 ADS ISIN: US44842L1035 | |||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 2,397 ADS | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2021-04-20 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Mr Paul Carter | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Independent Non-Executive Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Hutchison China MediTech Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | ADS each representing five Ordinary Shares of US$0.10 ADS ISIN: US44842L1035 | |||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 2,037 ADS | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2021-04-20 | |||
| f) | Place of the transaction | Outside a trading venue |
(c) Dr Karen Ferrante
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Dr Karen Ferrante | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Independent Non-Executive Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Hutchison China MediTech Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | ADS each representing five Ordinary Shares of US$0.10 ADS ISIN: US44842L1035 | |||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 2,397 ADS | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2021-04-20 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Mr Graeme Jack | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Independent Non-Executive Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Hutchison China MediTech Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | ADS each representing five Ordinary Shares of US$0.10 ADS ISIN: US44842L1035 | |||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 2,397 ADS | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2021-04-20 | |||
| f) | Place of the transaction | Outside a trading venue |
(e) Professor Tony Mok
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Professor Tony Mok | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Independent Non-Executive Director | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Hutchison China MediTech Limited | |||
| b) | LEI | 2138006X34YDQ6OBYE79 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code | ADS each representing five Ordinary Shares of US$0.10 ADS ISIN: US44842L1035 | |||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 2,397 ADS | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A | |||
| e) | Date of the transaction | 2021-04-20 | |||
| f) | Place of the transaction | Outside a trading venue |
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For further discussion of these and other risks, see HUTCHMED's filings with the U.S. Securities and Exchange Commission and on AIM. HUTCHMED undertakes no obligation to update or revise the information contained in this announcement, whether as a result of new information, future events or circumstances or otherwise.
| Investor Enquiries | |
| Mark Lee, Senior Vice President | +852 2121 8200 |
| Annie Cheng, Vice President | +1 (973) 567 3786 |
| Media Enquiries | |
| Americas - Brad Miles, Solebury Trout | +1 (917) 570 7340 (Mobile) bmiles@troutgroup.com |
| Europe - Ben Atwell / Alex Shaw, FTI Consulting | +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) HUTCHMED@fticonsulting.com |
| Asia - Joseph Chi Lo / Zhou Yi, Brunswick | +852 9850 5033 (Mobile) / +852 9783 6894 (Mobile) HUTCHMED@brunswickgroup.com |
| Nominated Advisor | |
| Freddy Crossley / Atholl Tweedie, Panmure Gordon (UK) Limited | +44 (20) 7886 2500 |